Nanotech'ed RNA drug reduces ovarian cancer tumors by 83 percent
Tuesday, February 12, 2013 - 16:00
in Health & Medicine
By loading fragile RNA into silicon nanoparticles, researchers have found a new drug delivery system can reduce the size of ovarian tumors by as much as 83 percent -- and stop tumor growth in chemotherapy-resistant ovarian cancer tissue.